KOCAA
MIRM icon

Knights of Columbus Asset Advisors’s Mirum Pharmaceuticals MIRM Stock Holding History

Knights of Columbus Asset Advisors’s Portfolio MIRM Stock Details MIRM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.79M Buy
23,831
+7
+0% +$703 0.14% 160
2026
Q1 		$2.2M Buy
23,824
+4,325
+22% +$407K 0.12% 187
2025
Q4 		$1.54M Sell
19,499
-616
-3% -$44.2K 0.09% 226
2025
Q3 		$1.47M Buy
20,115
+847
+4% +$53.8K 0.08% 231
2025
Q2 		$981K Sell
19,268
-489
-2% -$21.8K 0.06% 246
2025
Q1 		$890K Sell
19,757
-26,245
-57% -$1.24M 0.06% 239
2024
Q4 		$1.9M Buy
46,002
+116
+0.3% +$4.83K 0.13% 196
2024
Q3 		$1.79M Sell
45,886
-58,979
-56% -$2.35M 0.12% 197
2024
Q2 		$3.59M Buy
104,865
+2,587
+3% +$67.8K 0.23% 148
2024
Q1 		$2.57M Sell
102,278
-14,366
-12% -$395K 0.19% 175
2023
Q4 		$3.44M Buy
116,644
+58,773
+102% +$1.78M 0.22% 190
2023
Q3 		$1.83M Buy
57,871
+817
+1% +$22.4K 0.17% 189
2023
Q2 		$1.48M Buy
57,054
+49,807
+687% +$1.32M 0.13% 220
2023
Q1 		$174K Buy
+7,247
New +$165K 0.02% 306

Other funds holding MIRM

FLSM
Frazier Life Sciences Management Palo Alto, California $4.59B AUM 237.58% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $33.3B AUM 44.76% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Knights of Columbus Asset Advisors's MIRM Position: Q2 2026 in Review

Knights of Columbus Asset Advisors increased its Mirum Pharmaceuticals (MIRM) stake by 0.03% in Q2 2026, buying an estimated $703 and bringing the position to 23,831 shares worth $2.79M. The position accounts for 0.14% of the portfolio, ranked #160.

Knights of Columbus Asset Advisors first reported a position in MIRM in Q1 2023 and has held it in 14 quarters since. The position peaked at $3.59M in Q2 2024. 327 funds tracked by Wall St. Rank hold MIRM as of Q2 2026.

  • Knights of Columbus Asset Advisors held 23,831 shares of Mirum Pharmaceuticals worth $2.79M as of Q2 2026.
  • Knights of Columbus Asset Advisors bought 7 Mirum Pharmaceuticals shares in Q2 2026, an estimated $703.
  • Mirum Pharmaceuticals made up 0.14% of Knights of Columbus Asset Advisors's portfolio in Q2 2026, its #160 holding.
  • Knights of Columbus Asset Advisors first reported a position in Mirum Pharmaceuticals in Q1 2023 and has held it in 14 quarters since.
  • Knights of Columbus Asset Advisors's Mirum Pharmaceuticals position peaked at $3.59M in Q2 2024.
  • 327 funds tracked by Wall St. Rank held Mirum Pharmaceuticals as of Q2 2026.

Based on Knights of Columbus Asset Advisors's 13F filing for Q2 2026, filed 31 Jul 2026.